Cetera Investment Advisers’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Cetera Investment Advisers’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-24,180	Closed	-$12K	–	638
2019 Q4	$12K	Buy	+24,180	New	+$58.6K	﹤0.01%	582

Cetera Investment Advisers's MLNT Position: Q1 2020 in Review

Cetera Investment Advisers sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 24,180 shares — an estimated $12K sold.

Cetera Investment Advisers first reported a position in MLNT in Q4 2019 and held it in 1 quarter. The position peaked at $12K in Q4 2019. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

Cetera Investment Advisers reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Cetera Investment Advisers sold 24,180 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $12K.
Cetera Investment Advisers first reported a position in Melinta Therapeutics, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
Cetera Investment Advisers's Melinta Therapeutics, Inc. Common Stock position peaked at $12K in Q4 2019.
2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Cetera Investment Advisers's 13F filing for Q1 2020, filed 8 May 2020.